Cardiovascular
Stable Angina
November 1999
Clinical Focus*
- Is one class of anti-anginals (beta-blockers, nitrates, or calcium antagonists) superior as monotherapy in terms of occurrence of angina, nitroglycerin use, exercise tolerance, or adverse events leading to study withdrawal in patients
with stable angina?
- Is one class of drugs superior when outcomes over a longer period of time—such as recurrent myocardial infarction or death—are examined?
- Are there any alternative medical treatments—including chelation therapy, acupuncture, herbal medications, and garlic—that are superior to placebo in any outcome measure for patients with stable angina?
*Addressed in the summary or evidence report.
An Evaluation of Beta-Blockers, Calcium Antagonists, Nitrates, and Alternative Therapies for Stable Angina
Summary (Publication No. 00-E002, November 1999)
Evidence Report (Publication No. 00-E003, November 1999)
(File Download)
Selected Publications
EPC: UCSF-Stanford
Topic Nominators: American College of Cardiology, American Heart Association Task Force on Practice Guidelines, American College of Physicians
Return to Quick Menu: Evidence Report Topics
Return to Evidence-based Practice